R
Rune Labs
Rune Labs | Software and data platform for neuromodulation
About Rune Labs
Rune Labs operates in the neuroscience and healthcare sector, focusing on developing software solutions for neuromodulation applications. The company aims to accelerate the next wave of brain-machine interfaces, which are designed to treat chronic neurological diseases such as Parkinson's, epilepsy, and Alzheimer's. By providing advanced software, Rune Labs helps restore mobility to paralyzed patients, speed up stroke recovery, and potentially enhance cognitive functions and mood control. The business primarily serves medical researchers, healthcare providers, and patients, operating within the global healthcare and medical technology markets. Rune Labs generates revenue through the development and licensing of its specialized software, which is integral to the functionality of neuromodulation devices.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- San Francisco, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 61.3/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Neurology, Medical Data, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2024 | $12M | $114M | Brain Foundation · TruVenturo GmbH · Eclipse Ventures · DigiTx Partners | ↗ |
| SERIES A✓Equity / VC | Sep 2021 | $23M | $91M | Moment Ventures · DigiTx Partners · Eclipse Ventures | — |
Growth signals
Latest recorded traffic for Rune Labs is 3.2K monthly website visits, down 20% over the last three months. Rune Labs's team declined 15.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
DigiTx Partners
Series A5 investors entered at this stage
Eclipse Ventures
Moment Ventures
Brain Foundation
TruVenturo GmbH
Nexus NeuroTech Ventures
Other known investors6 additional known investors
Band of Angels
Carnrite Ventures
City Light Capital
Daybreak Partners
Loup Ventures
Village Global
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rune Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rune Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







